Clinical genetic testing in four highly suspected pediatric restrictive cardiomyopathy cases

Abstract

Background Restrictive cardiomyopathy (RCM) presents a high risk for sudden cardiac death in pediatric patients. Constrictive pericarditis (CP) exhibits a similar clinical presentation to RCM and requires differential diagnosis. While mutations of genes that encode sarcomeric and cytoskeletal proteins may lead to RCM, infection, rather than gene mutation, is the main cause of CP. Genetic testing may be helpful in the clinical diagnosis of RCM. Methods In this case series study, we screened for TNNI3, TNNT2, and DES gene mutations that are known to be etiologically linked to RCM in four pediatric patients with suspected RCM. Results We identified one novel heterozygous mutation, c.517C>T (substitution, position 517 C → T) (amino acid conversion, p.Leu173Phe), and two already known heterozygous mutations, c.508C>T (substitution, position 508, C → T) (amino acid conversion, p.Arg170Trp) and c.575G>A (substitution, position 575, G → A) (amino acid conversion, p.Arg192His), in the TNNI3 gene in three of the four patients. Conclusion Our findings support the notion that genetic testing may be helpful in the clinical diagnosis of RCM.

Challenging of ECMO application in pediatric restrictive cardiomyopathy: case report of a novel TNNI3 variant

“…RCM often manifests as an inherited disease within familial contexts (6)(7)(8)(9). The genetic underpinnings of RCM encompass mutations or alterations in genes responsible for maintaining heart muscle structure and function.…”